These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13789507)

  • 21. [Coxsackie and ECHO virus isolations in 1958 (Correlation between disease and virus type)].
    LENNARTZ H
    Zentralbl Bakteriol; 1959 Nov; 176():385-9. PubMed ID: 13853627
    [No Abstract]   [Full Text] [Related]  

  • 22. [INCIDENTS AND ACCIDENTS OF TREATMENT OF TRYPANOSOMIASIS WITH MEL W. (SECOND NOTE APROPOS OF 40 NEW OBSERVATIONS)].
    COLLOMB H; AYATS H; MARTINO P; LARIVIERE M
    Bull Soc Med Afr Noire Lang Fr; 1964; 9():325-9. PubMed ID: 14277992
    [No Abstract]   [Full Text] [Related]  

  • 23. Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):96-100. PubMed ID: 13638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [First results of the treatment of human trypanosomiasis with Mel B].
    FERREIRA FS; de ALMEIDA CL; PIRES FM
    An Inst Med Trop (Lisb); 1950 Jul; 7():35-52. PubMed ID: 14819606
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical aspects of serous meningitis caused by Coxsackie virus].
    KIRICHINSKAIA Ia; KOLESNIKOV GF; KRASNOV BG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():273-9. PubMed ID: 14409312
    [No Abstract]   [Full Text] [Related]  

  • 26. [Eye diseases and toxic amblyopia in the course of treatment of human African trypanosomiasis].
    DEBEIR O
    Ann Soc Belg Med Trop (1920); 1954 Dec; 34(6):841-74. PubMed ID: 14362170
    [No Abstract]   [Full Text] [Related]  

  • 27. Mel W, a new trypanosomicidal agent derived from mel B.
    FRIEDHEIM EA; DE JONGH RT
    Trans R Soc Trop Med Hyg; 1959 May; 53(3):262-9. PubMed ID: 13669031
    [No Abstract]   [Full Text] [Related]  

  • 28. [VIRAL ENCEPHALITIS AT DAKAR (ENTEROVIRUSES AND ADENOVIRUSES)].
    COLLOMB H; ARMENGAUD M; BAYLET R; GUERINEAU P
    Rev Neurol (Paris); 1963 Jun; 108():784-9. PubMed ID: 14091977
    [No Abstract]   [Full Text] [Related]  

  • 29. Problems in the treatment of human trypanosomiasis.
    FERREIRA FS
    An Inst Med Trop (Lisb); 1952 Sep; 9(3):721-6. PubMed ID: 13092453
    [No Abstract]   [Full Text] [Related]  

  • 30. Coxsackie B2 virus causing simultaneous hand, foot and mouth disease and encephalitis.
    Conway SP
    J Infect; 1987 Sep; 15(2):191. PubMed ID: 2822814
    [No Abstract]   [Full Text] [Related]  

  • 31. Trypanosoma rhodesiense encephalitis. Clinicopathological study of five cases of encephalitis and one of mel B hemorrhagic encephalopathy.
    Manuelidis EE; Robertson DH; Amberson JM; Polak M; Haymaker W
    Acta Neuropathol; 1965 Nov; 5(2):176-204. PubMed ID: 5886200
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
    Scena MR
    Cent Afr J Med; 1988 Nov; 34(11):264-8. PubMed ID: 3252975
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isolation of a pathogen related to the Coxsackie virus; clinical diagnosis with the complement fixation reaction].
    WIRTH J; THELIN F
    Praxis; 1950 Nov; 39(44):948-52. PubMed ID: 14797535
    [No Abstract]   [Full Text] [Related]  

  • 35. [ENTEROVIRUSES (POLIOMYELITIS, COXSACKIE, ECHO) AND DISEASES OF THE NERVOUS SYSTEM. CRITICAL REVIEW AND PERSONAL EXPERIENCE].
    THIEFFRY S
    Rev Neurol (Paris); 1963 Jun; 108():753-76. PubMed ID: 14091974
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possibility of symbiosis between Coxsackie virus and that of Theiler encephalitis].
    LEVADITI C; VAISMAN A
    Ann Inst Pasteur (Paris); 1951 Aug; 81(2):207-10. PubMed ID: 14868871
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical characteristics of diseases caused by viruses of the Coxsackie & ECHO group].
    LESHCHINSKAIA EV
    Pediatriia; 1959 Feb; 14(2):80-6. PubMed ID: 13645167
    [No Abstract]   [Full Text] [Related]  

  • 38. [Practical value of the complement fixation reaction in trypanosomiasis gambiense. II. Complement fixation reaction in a case of relapse after medicinal treatment].
    EVENS F; SCHOENAERS F; NEUJEAN G; KAECKENBEEK A; STYNS J
    Ann Soc Belg Med Trop (1920); 1953 Oct; 33(5):389-402. PubMed ID: 13139073
    [No Abstract]   [Full Text] [Related]  

  • 39. Encephalitis due to group B, type 5 Coxsackie virus.
    WALKER SH; TOGO Y
    Am J Dis Child; 1963 Feb; 105():209-12. PubMed ID: 13998519
    [No Abstract]   [Full Text] [Related]  

  • 40. [Products with a melaminyl radical in the treatment of human trypanosomiasis gambiense].
    JONCHERE H; GOMER J; REYNAUD R
    Bull Soc Pathol Exot Filiales; 1953; 46(3):386-96. PubMed ID: 13094465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.